Stay updated with breaking news from Human Acellular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Five-year data demonstrate the potential of the Human Acellular VesselTM(HAV) to be a durable and safe option for vascular access for routine, long-term hemodialysis --
Humacyte Announces the Appointments of Three Surgical and Cardiovascular Opinion Leaders to Advisory Roles - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment
31.12.2021 - DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) - Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of ... Seite 1